A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.126
Full Text
Open PDFAbstract
Available in full text
Date
April 21, 2015
Authors
Publisher
Springer Science and Business Media LLC